Key documents:

• Agenda
• List of participants
• Compilation of national abstracts
• Objectives of the 4 DRD workshops
• Minutes DRD Day 1
• Minutes joint DRD and DRID meeting Day 2
• Minutes DRID and Joint meetings

• Presentations

• Day 1 - 16 October 2013 am

• DRID Plenary
  • Introduction, meeting objectives and overview of DRID activities - L. Wiessing, EMCDDA
  • HIV outbreak in Greece, results of the Aristotle study - V. Sypsa, Greece
  • Important differences in injecting risks between people who inject drugs in eastern and western Europe - M. Raag, Estonia
  • EMIS results on MSM in Spain – new drugs and sexual risks of HIV - C. Folch, Spain)
  • Incidence of drug injection: systematic review and meta-analysis of cohort studies among at-risk populations - M.J. Bravo & B. Iciar Indave, Spain
  • DRID strategy review, presentation of expert meeting results - L. Wiessing, EMCDDA
• DRD Workshops
  • Workshop 1
    • Pooled EU cohorts - M. Trapencieris, Latvia
    • Amphetamine users study: overall and cause specific mortality - M. Trapencieris, Latvia
  • Workshop 2
    
    • Fentanyl: trendspotting overview and focus on deaths - J. Mounteney, EMCDDA
    • Update on fentanyl national trends reported on 2013 - E. Vuori, Finland
    • Risk of bias in vital statistics - E. Vuori
    • Medicines in the context of the Early Warning System (EWS) - M. Evans-Brown, EMCDDA
    • Tramadol-related deaths: situation in the United Kingdom - J. Corkery, United Kingdom
    • Tramadol-related deaths: results of the 2013 survey for discussion - J. Matias, EMCDDA
  • Workshop 3
    
    • Monitor for drug-related emergencies (MDI) and cannabis-related emergency data - E. Croes, The Netherlands
    • National Trends in cannabis-related emergencies: E. Januševičienė, Lithuania; H. Saelen, Denmark; V. Mravčík, Czech Republic
    • Barcelona: experience of acute drug-related poisoning monitoring - A. Domingo-Salvany, Spain
  • Workshop 4
    
    • Monitoring drug-induced deaths in Turkey - B. Sam, Turkey
    • DRD underestimation, overestimation, biases in reporting? - A.-C. Brisacier, France
    • Monitoring drug-induced deaths in Slovakia - J. Sidlo, Slovakia
• Day 1 - 16 October 2013 pm
  
• DRD Plenary
  • Objectives of the 2013 meeting: Key indicators progress and work in progress - I. Giraudon, EMCDDA
  • Drug-induced deaths reported in 2013: preliminary results for discussion - J. Matias, EMCDDA
  • Enhancing toxicovigilance of new drugs (including reporting of deaths) - M. Evans-Brown, EMCDDA
  • Prevalence Estimates, Treatment Data and DRD Composing the Puzzle - Adherence Rate to OST - C. Klein, Austria
  • Developments in the Norwegian overdose situation - T. Clausen, Norway
• DRID Workshops
  • Workshop 1 - Monitoring HBV vaccination through the existing EMCDDA data system - M. Cruciani, Italy
  • Workshop 2 - Burden of HCV disease - M. Salminen, Finland
  • Workshop 3 - Capacity building and feedback to service providers, networking of experts - A. Fotiou, Greece & F. Denecker, EMCDDA
  • Workshop 4 - Diagnostic testing prevalence data - C. Matheï, Belgium & M. Rosińska, Poland
  • Workshop 5 - Reporting and use of subnational data, categorising and grading data, reporting burden - E. Kalamara, S. Sleiman & A. Noor, EMCDDA
  • Workshop 6 - Monitoring other infections (TB, HAV, STIs, spore-forming bacteria, MRSA) - H. Blystad, Norway
  • Workshop 7 - Using TDI data for DRID / DRID study in treatment centres - M.J. Bravo, Spain & J. Vicente, EMCDDA
  • Workshop 8 - Non-IDUs, other groups (steroid users, MSM who use drugs) - V. Hope, United Kingdom
• Day 2 - Thursday, 17 October 2013
  
• Joint Plenary DRD-DRID
  
  • Mortality cohort studies among drug users
    • Preliminary findings of the 2013 record linkage cohort study - A.C. Brisacier, France
    • Overview and main findings of the pooled EU cohorts - I. Giraudon, EMCDDA
    • Pooled EU cohorts – implications of age differences in mortality - M. Trapencieris, Latvia
  • Mortality related to infection
    • Estimation of HIV mortality related to IDU - I. Giraudon, EMCDDA
    • Mortality trends in PLHIV in Latvia and insight from cohort studies - A. Karnīte & M. Trapencieris, Latvia
    • Ten year trends in HIV and service provision in Europe - M. Busch, Austria
    • ECDC/EMCDDA Joint anthrax prevention guidance for PWID - C. Bartels, ECDC
  • Parallel session: Harm related to new psychoactive drugs and methamphetamine
    • Establishing the acute harms associated with the use of new psychoactive substances: what is available, deficiencies in current datasets, potential for poisons centre data, Euro-DEN data collection - D. Wood, United Kingdom
  • Parallel session: Hepatitis C infection in PWID
    • Incidence of hepatitis C infection among people injecting drugs in the EU (with a focus on the UK) - K. Cullen & V. Hope, United Kingdom
    • Hep C initiative -E. Schatz, Netherlands
  • Prevention of overdose and infection
    
    • Improvement in the recognition and assessment of acute drug toxicity in the pre-hospital environment - P. Dargan, United Kingdom
    • Pre-provision of naloxone to prevent heroin overdose deaths: evidence, myths and UK experience - J. Strang, United Kingdom
    • Prevention of overdose and infection. Experience from Villa Maraini Foundation/Italian Red Cross/International Federation Red Cross Red Crescent (IFRC) - F. Patruno, Italy
    • State of play of the 2003 Council Recommendation on the prevention and reduction of health-related harm: focus on trends in DRD and responses - C. Klein, Austria
• Day 3 - Friday, 18 October 2013
  
  • HIV outbreaks among PWID in Europe - linking economic, service provision and epidemiological data
  • HIV among people who inject drugs in Europe: update of a regional risk assessment
  • HIV Risk assessment
    • EMCDDA–ECDC updated joint EU risk assessment 2013 - D. Hedrich, EMCDDA
    • The impact of the economic downturn on HIV among drug users in Europe – a conceptual framework - A. Fotiou, Greece
    • HIV outbreaks among PWID in Europe – linking economic, epidemiological and service provision data - C. Storti, EMCDDA
  • Parallel workshops - Country updates group 1
    
    • Greece - A. Fotiou
    • Romania - A. Botescu
    • Hungary - A. Tarján
    • Bulgaria - V. Bogdanova
    • Turkey - E. Mutlu
    • Cyprus - N. Fotsiou
    • Portugal - D. Duran
  • Parallel workshops - Country updates group 2
    
    • Latvia - A. Karnīte
    • Estonia - M. Salekešin
    • Lithuania - V. Dobrovolskij
    • Poland - M. Struzik
    • Slovakia - S. Slezáková & Z. Alexandercikova
    • United Kingdom - V. Hope

Disclaimer:

The EMCDDA is not responsible for the content of the presentations; the responsibility lies with the authors.

For further use of content of the presentations: If you wish to make use of any parts of a presentation, please contact the author directly (the e-mail and contact details are in the 'List of participants').